BioSpace News Archive

Codexis, Inc. today announced the Company will attend the Jefferies Global Healthcare Conference, being held June 5-6, 2024, in New York, New York.

Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2024.

Xtant Medical Holdings, Inc. today announced that Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29 in Minneapolis.

Adagene Inc. today announced its participation in multiple investor conferences in June 2024.

Amneal Pharmaceuticals, Inc. announced that it has begun supplying its over-the-counter Naloxone Hydrochloride Nasal Spray, USP, 4mg to U.S. retail pharmacies and the State of California.

In the never ending quest for efficient cancer treatments, the evolving field has forced researchers to explore new avenues for taking on this aggressive illness.

Kronos Bio, Inc. today announced that the company would participate in three upcoming healthcare conferences and events.

In a paper published in Science Translational Medicine, researchers from City of Hope®, one of the largest cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses, report that they have discovered advances in predicting kidney failure in type 1 diabetes patients.

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.432 per share for the third quarter of 2024.

Rayonier Advanced Materials Inc. today announced that President and Chief Executive Officer, De Lyle Bloomquist, will meet with investors in one-on-one settings as well as a group presentation at the Stifel Cross Sector Insight Conference on June 5, 2024.